Compounds > tazobactam
Page last updated: 2024-09-03

tazobactam and Bacterial Infections, Gram-Positive

tazobactam has been researched along with Bacterial Infections, Gram-Positive in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (18.75)18.2507
2000's6 (37.50)29.6817
2010's5 (31.25)24.3611
2020's2 (12.50)2.80

Authors

AuthorsStudies
Courvalin, P; Decré, D; Høiby, EA; Meziane-Cherif, D; Périchon, B1
Cho, SY; Chung, YN; Heo, WY; Huh, HJ; Kang, OK; Lee, JK; Lee, NY; Sung, DH; Yoo, IY1
Cantón, R; Gomes, R; Martins-Oliveira, I; Pérez-Viso, B; Pina-Vaz, C; Quintas, S; Rodrigues, AG; Silva-Dias, A1
Jacobus, NV; McDermott, LA; Snydman, DR1
Darouiche, RO; Steenbergen, J; Umeh, O; Wagenlehner, FM; Yuan, G1
Botes, J; Boutlis, CS; Glasgow, AL; Jones, SL; Riordan, JW1
Armstrong, ES; Farrell, DJ; Palchak, M; Steenbergen, JN1
Adams, CA; Cioffi, WG; Connolly, MD; Gregg, S; Heffernan, DS; Monaghan, SF; Stephen, A; Thakkar, RK1
Kwan, TH; Siu, YP; Tong, MK; Yung, CY1
Rice, LB1
Abbruzzetti, A; Cirioni, O; Di Matteo, F; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C1
Betschel, S; Kreiswirth, B; Low, DE; Willey, BM1
Atwood, E; DiTore, V; Landman, D; Patel, K; Quale, J; Saurina, G1
Aznar, E; Climent, MA; Máiquez, J; Palau, J; Picón, I1
Cross, JM; May, AK; McGwin, G; Melton, SM; Moser, SA; Rue, LW1
Allen, MC; Bradley, SJ; Goldstone, AH; Scott, GM; Sher, HA; Wilson, AL1

Reviews

2 review(s) available for tazobactam and Bacterial Infections, Gram-Positive

ArticleYear
Antimicrobial resistance in gram-positive bacteria.
    The American journal of medicine, 2006, Volume: 119, Issue:6 Suppl 1

    Topics: Animals; beta-Lactamase Inhibitors; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Enterococcus faecalis; Gastrointestinal Tract; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin Resistance

2006
Enterococcis: pathogens of the 90s.
    The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 1994, Issue:573

    Topics: Abdominal Abscess; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacterial Infections; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin

1994

Trials

3 trial(s) available for tazobactam and Bacterial Infections, Gram-Positive

ArticleYear
Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI).
    Lancet (London, England), 2015, May-16, Volume: 385, Issue:9981

    Topics: Adult; Aged; Anti-Infective Agents, Urinary; Cephalosporins; Double-Blind Method; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Levofloxacin; Male; Middle Aged; Penicillanic Acid; Pyelonephritis; Tazobactam; Treatment Outcome; Urinary Tract Infections; Young Adult

2015
In Vitro Activity of Ceftolozane-Tazobactam against Anaerobic Organisms Identified during the ASPECT-cIAI Study.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Bacteroides Infections; Cephalosporins; Drug Therapy, Combination; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intraabdominal Infections; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam

2016
The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:2

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Glycopeptides; Gram-Positive Bacterial Infections; Hematology; Hospital Units; Humans; Infection Control; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam

1999

Other Studies

11 other study(ies) available for tazobactam and Bacterial Infections, Gram-Positive

ArticleYear
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2

    Topics: Amino Acid Sequence; beta-Lactams; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin Resistance; Penicillinase; Sequence Alignment; Sequence Analysis, DNA; Substrate Specificity

2008
First Case of Bacteremia Caused by Coprobacillus catenaformis.
    Annals of laboratory medicine, 2020, Volume: 40, Issue:5

    Topics: Aged; Anti-Bacterial Agents; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Firmicutes; Gram-Positive Bacterial Infections; Humans; Laminectomy; Pedicle Screws; Piperacillin; Spinal Cord; Tazobactam

2020
Evaluation of ultra-rapid susceptibility testing of ceftolozane-tazobactam by a flow cytometry assay directly from positive blood cultures.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020, Volume: 39, Issue:10

    Topics: Anti-Bacterial Agents; Blood Culture; Cephalosporins; Flow Cytometry; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Portugal; Spain; Tazobactam

2020
Activity of ceftolozane-tazobactam against a broad spectrum of recent clinical anaerobic isolates.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2

    Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteroides fragilis; Cephalosporins; Clostridium; Drug Combinations; Fusobacterium; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Prevotella; Propionibacterium; Tazobactam

2014
Two cases of spondylodiscitis caused by Parvimonas micra.
    Internal medicine journal, 2015, Volume: 45, Issue:10

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamase Inhibitors; C-Reactive Protein; Clavulanic Acid; Clindamycin; Discitis; Female; Gram-Positive Bacterial Infections; Humans; Magnetic Resonance Imaging; Male; Penicillanic Acid; Peptostreptococcus; Tazobactam

2015
Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    The Journal of surgical research, 2013, Volume: 181, Issue:2

    Topics: Acetamides; Anti-Bacterial Agents; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Retrospective Studies; Tazobactam; Treatment Outcome; Vancomycin; Wounds and Injuries

2013
Piperacillin/tazobactam-induced acute delirium in a peritoneal dialysis patient.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004, Volume: 19, Issue:5

    Topics: Anti-Bacterial Agents; Bacterial Infections; Confusion; Delirium; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Hallucinations; Humans; Kidney Failure, Chronic; Male; Middle Aged; Penicillanic Acid; Peritoneal Dialysis, Continuous Ambulatory; Piperacillin; Tazobactam

2004
Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
    Critical care medicine, 2008, Volume: 36, Issue:1

    Topics: Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gram-Positive Bacterial Infections; Male; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Rats; Rats, Wistar; Shock, Septic; Tazobactam; Treatment Outcome

2008
Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 23, Issue:5

    Topics: Ampicillin; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Gastrointestinal Diseases; Gram-Positive Bacterial Infections; Humans; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam; Vancomycin

1996
[Cost of antibiotic therapy in neutropenic patients undergoing peripheral blood stem cell transplantation for breast cancer].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2000, Volume: 13, Issue:2

    Topics: Amikacin; Antineoplastic Agents; Breast Neoplasms; Drug Costs; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Hospital Costs; Humans; Neutropenia; Penicillanic Acid; Piperacillin; Spain; Tazobactam; Teicoplanin; Transplantation Conditioning; Treatment Failure; Treatment Outcome; Vancomycin

2000
Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit.
    Shock (Augusta, Ga.), 2000, Volume: 14, Issue:3

    Topics: Burn Units; Cephalosporins; Clinical Protocols; Cross Infection; Drug Utilization; Enterococcus; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Methicillin Resistance; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Staphylococcal Infections; Staphylococcus aureus; Tazobactam; Vancomycin; Vancomycin Resistance; Wounds and Injuries

2000